Company intelligence / Profile preview
Altaire Pharmaceuticals
Aquebogue, NY, USAfda.gov ↗
- Ownership
- Private
- Employees
- ~42
- Development stage
- Other
01
Overview
Altaire Pharmaceuticals manufactures commercial sterile ophthalmic products for both prescription and over-the-counter use. The company has also developed or licensed technologies aimed at new therapies in the respiratory space but no clinical results are publicly available as of June 2025.
- Therapeutic areas
- OphthalmologyPulmonology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Seeking strategic partners especially in orphan drug portfolio/licensing collaborations; specific partners not listed as of June 2025
Beyond the preview
Go deeper on Altaire Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altaire Pharmaceuticals.